Influence of pulmonary function on spacer use for HFA-salbutamol inhalation in asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 126s Year: 2005
Comparison of FENO reduction in asthmatic children treated with inhaled budesonide-MDI with two-valved, non valved, or home-made spacers Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Comparison of bronchodilator effect of salbutamol delivered via MDI + spacer and DPI in children with asthma Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
Metered dose inhaler with spacer versus nebulizer in children with acute bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 429s Year: 2002
The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005
Comparison of pulmonary and systemic absoption of two HFA formulations of salmeterol in healthy subjects Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009
Evaluation of the acute bronchodilator effect of beclomethasone/formoterol fixed combination on central and peripheral airway dimensions in asthmatic patients Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children Source: Eur Respir J 2007; 29: 299-306 Year: 2007
Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Comparative evaluation of formoterol budesonide combination MDI and salbutamol MDI for reversibility testing in patients with obstructive airways disease Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010
Comparative lung bioavailability of fluticasone/salmeterol via breath actuated vortex spacer and conventional plastic spacers Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001
Does the inhalation device affect the bronchodilatory dose response curve of Salbutamol in asthma- and COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 473s Year: 2003
Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol Source: Eur Respir J 2004; 24: Suppl. 48, 581s Year: 2004
Bronchodilator response to different doses of albuterol in asthmatic children Source: Annual Congress 2007 - Crossroads between paediatric respiratory physiology and epidemiology Year: 2007
Unspecific bronchial provocation with methacholine: comparing an aerosol bolus technique and a technique applying controlled inhalations Source: Eur Respir J 2006; 28: Suppl. 50, 218s Year: 2006
In vitro comparison of output and particle size distribution of budesonide from metered-dose inhaler with three spacer devices during pediatric tidal breathingSource: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005
Comparison of inhaler and nebuliser bronchodilator treatments in COPD attacks Source: Eur Respir J 2002; 20: Suppl. 38, 244s Year: 2002